Skip to main content

Serum Cholinesterase: Genetics, Enzymology, Diagnostic Use and the Association with Clinical Disorders

  • Chapter
Esterases, Lipases, and Phospholipases

Part of the book series: NATO ASI Series ((NSSA,volume 266))

  • 97 Accesses

Abstract

Cholinesterase (EC 3.1.1.8, CHE or BChE) also called butyrylcholinesterase or serum cholinesterase, has evoked the interest of geneticists, biochemists, pharmacologists, and clinicians, particularly hepatologists. Recent molecular biological investigations have thrown light on new facets of this plasma enzyme. Some of them will be reported, and a number of still open questions discussed, preferably under clinical aspects, without claiming comprehensiveness.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kalow, K. and K. Genest, A method for the detection of atypical forms of human cholinesterase, determination of dibucaine numbers. Can. J. Biochem. 35: 1957; 339–346

    PubMed  CAS  Google Scholar 

  2. Harris, H. and M. Whittaker, Differential inhibition of human serum cholinesterase with fluoride: recognition of two new phenotypes. Nature19I: I961; 496–498

    Google Scholar 

  3. Liddell, J., H. Lehmann and E. Silk, A “silent” pseudocholinesterase gene. Nature 193: 1962; 561–562

    Article  PubMed  CAS  Google Scholar 

  4. Bartels, C.F., F.S. Jensen, O. Lockridge, A.F.L. van der Spek, H.M. Rubinstein, T. Lubrano and B.N. La Du, DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am. J. Hum. Genet. 50: 1992; 1086–1103

    PubMed  CAS  Google Scholar 

  5. Rubinstein, A.A. Dietz and T. Lubrano, Elk, another quantitative variant at cholinesterase locus 1. J. Med. Genet. 15: 1978; 27–29

    Article  PubMed  CAS  Google Scholar 

  6. Garry, P.J., A.A. Dietz, T. Lubrano, P.C. Ford, K. James and H.M. Rubinstein, J. med. Genet. 13: 1976; 38–42

    Article  PubMed  CAS  Google Scholar 

  7. Whittaker, M. and J.J. Britten, Elh, a new allele at cholinesterase locus 1. Hum. Hered. 37: 1987; 54–58

    Article  PubMed  CAS  Google Scholar 

  8. Schmidt, E., R. Klauke and F.W. Schmidt, Proposed routine method for phenotyping of cholinesterase (CHE) locus El variants with butyrylcholine as substrate at 37°C, Fresenius Z. Anal. Chem. 330: 1988; 364

    Article  Google Scholar 

  9. Lockridge, O. and B. N. La Du, Structure of the human butyrylcholinesterase gene and expression in mammalian cells, in: Cholinesterases, J. Massoulié et al. eds., Am. Chem. Soc. Washington, DC, 1991, 168–171

    Google Scholar 

  10. Arpagaus, M., M. Kott, K.P. Vatsis, C.F. Bartels, B.N. La Du and O. Lockridge, Structure of the gene for human butyrylcholinesterase. Evidence for a single copy. Biochemistry 29: 1990; 124–131

    Article  PubMed  CAS  Google Scholar 

  11. Gaughan, G., H. Park, J. Priddle, I. Craig and S. Craig, Refinement of the localization of human butyrylcholinesterase to chromosome 3g26.1-g26.2 using a PCR-derived probe. Genomics 11: 1991; 455–458

    Article  PubMed  CAS  Google Scholar 

  12. McGuire, M.C., C.P. Nogueira, C.F. Bartels, H. Lightstone, A. Hajra, A.F. van der Spek, O. Lockridge and B.N. La Du, Identification of the structural mutation responsible for the dibucaine-resistant (atypical) variant form of human serum cholinesterase. Proc. Nat. Acad. Sci. U.S.A. 86: 1989; 953–957

    Article  CAS  Google Scholar 

  13. Nogueira, C.P., C.F. Bartels, M.C. McGuire, S. Adkins, T. Lubrano, H.M. Rubinstein, H. Lightstone, A.F. van der Spek, O. Lockridge and B.N. La Du, Identification of two different point mutations associated with the fluoride-resistant phenotype for human butyrylcholinesterase. Am. J. Hum. Genet. 51: 1992; 821–828

    PubMed  CAS  Google Scholar 

  14. Jensen, F.S. C.F. Bartels and B.N. La Du, A DNA point mutation associated with the H-variant of human butyrylcholinesterase, in: Cholinesterases, J. Massoulié et al. eds. Am. Chem. Soc. Washington DC, 1991, 189

    Google Scholar 

  15. Whittaker, M. and J.J. Britten, Segregation of the sub(1)(j) gene for plasma cholinesterase in family studies. Hum. Her. 39: 1989; 1–6

    Article  CAS  Google Scholar 

  16. Bartels, C.F., K. James, B.N. La Du, DNA mutations associated with the human butyrylcholinesterase J-variant. Am. J. Hum. Genet. 50: 1992; 1104–1114

    PubMed  CAS  Google Scholar 

  17. Evans and J Wardell, On the identification and frequency of the J and K cholinesterase phenotypes in a Caucasian population. J. Med. genet. 21: 1984; 99–102

    Google Scholar 

  18. Bartels, C.F., O. Lockridge and B.N. La Du, DNA coding for the K polymorphism in linkage disequilibrium with atypical human butyrylcholinesterase complicates phenotyping, in: Cholinesterases, J. Massoulié et al. eds.Am. Chem. Soc., Washington, DC, 1991, 191

    Google Scholar 

  19. Szeinberg, A., S. Pipano, M. Assa, J.H. Medalie and H.N. Neufeld, High frequency of atypical pseudocholinesterase gene among Iraqi and Iranian Jews. Clin. Genet. 3: 1972; 123–127

    Article  PubMed  CAS  Google Scholar 

  20. Whittaker, M., Cholinesterase, Karger, Basel, 1986

    Google Scholar 

  21. Arnaud, J., H. Brun, R. Llobera and J. Constans, Serum cholinesterase polymorphism in France: an epidemiological survey of the deficient alleles detected by an automated micro-method. Ann. Hum. Biol. 18: 1991; 1–8

    Article  PubMed  CAS  Google Scholar 

  22. Chautard-Freire-Maia, E.A. S.L. Primo-Parmo, M.A. Canever de Lourenço and L. Culpi, Frequencies of atypical serum cholinesterase among Caucasians and Negroes from Southern Brazil. Hum. Hered. 34: 1984; 388–392

    Article  PubMed  CAS  Google Scholar 

  23. Evans, R.T., A. Walker and K.M. Bowness, Improved accuracy of cholinesterase phenotyping after participation in a proficiency survey. Clin. Chem. 33: 1987; 823–825

    PubMed  CAS  Google Scholar 

  24. Rosalki, S.B., Genetic influences on diagnostic enzymes in plasma. Enzyme 39: 1988; 95–109

    PubMed  CAS  Google Scholar 

  25. Masson, P., A. Chatonnet and O. Lockridge, Evidence for a single butyrylcholinesterase gene in individuals carrying the C5 plasma cholinesterase variant (CHE2). FEBS 262: 1990; 1 15–1 18

    Google Scholar 

  26. Harris, H., D.A. Hopkinson, E.B. Robson and M. Whittaker. Genetical studies on a new variant of serum cholinesterase detected by electrophoresis. Ann. Hum. Genet. 26: 1963; 359–382

    Article  CAS  Google Scholar 

  27. Masson, P., Molecular heterogeneity of human plasma cholinesterase, in: Cholinesterases, J. Massoulié et al. eds. Am. Chem. Soc. Washington, DC., 1991, 42–46

    Google Scholar 

  28. Soreq, H., R. Zamir, D. Zevin-Sonkin and H. Zakut, Human cholinesterase genes localized by hybridization to chromosomes 3 and 16. Hum. genet. 77: 1987; 325–328

    Article  PubMed  CAS  Google Scholar 

  29. Marazita, M.L., B.J.B. Keats, M.A. Spence, R.S. Sparkes, L.L. Field, M.C. Sparkes and M. Crist, Mapping studies of the serum cholinesterase-2-locus (CHE2). Hum. Genet. 83: 1989; 139–144

    Article  PubMed  CAS  Google Scholar 

  30. Eiberg, H., L.S. Nielsen, J. Klausen, M. Dahlen, M. Kristensen, M.L. Bisgaard, N. Moller and J. Mohr, Linkage between serum cholinesterase 2 (CHE2) and gamma-crystalline gene cluster (CRYG): assignment to chromosome 2. Clin. Genet. 35: 1989, 313–321

    Article  PubMed  CAS  Google Scholar 

  31. Gueirrero, J.F., S.E. Santos and G.F. Aguiar, Serum cholinesterase polymorphism (CHEZ and CHE2 loci) among several Indian groups from Amazon region of Brazil, and segregation of the C5 variant in families. Gene Geography 3: 1989; I I - 20

    Google Scholar 

  32. Steegmüller, H., On the geographical distribution of pseudocholinesterase variants. Humangenetik 26: 1975; 167–185

    PubMed  Google Scholar 

  33. Oimomi, M., J. Ohkawa, S. Saeki and S. Baba, A familial study of C5+cholinesterase and its frequency in the normal population. Gastroent. japon. 23: 1988; 680–683

    CAS  Google Scholar 

  34. Schmidt, E., F.W. Schmidt, A. Delbrück and E. Henkel, Variants of cholinesterase. Adv. Clin. Enzymol. 2: 1982; 55–66

    CAS  Google Scholar 

  35. Lockridge, O., H.W. Eckerson and B. N. La Du, Interchain disulphide bonds and subunit organization in human serum cholinesterase. J. biol. Chem. 254: 1979; 8324–8330

    CAS  Google Scholar 

  36. Fishman, J.B. and R.E. Fine, A trans Golgi-derived exocytic coated vesicle can contain both newly synthesized cholinesterase and internalized transferrin. Cell 48: 1987; 157–164

    Article  PubMed  CAS  Google Scholar 

  37. Ostergaard, D., J. Viby-Mogensen, H.K. Hand and L.T. Skovogaard, Half-life of plasma cholinesterase. Acta Anaesthesiol. Scand. 32: 1988; 266–269

    CAS  Google Scholar 

  38. Neitlich, H.W., Increased plasma cholinesterase activity and succinylcholine resistance: a genetic variant. J. clin. Invest. 45: 1966; 380–387

    Article  PubMed  CAS  Google Scholar 

  39. Yoshida, A. and A.G. Motulski, A pseudocholinesterase variant (E Cynthiana) associated with elevated plasma enzyme activity. Am. J. Hum. genet. 21: 1969; 486–498

    PubMed  CAS  Google Scholar 

  40. Delbrück, A. and E. Henkel, A rare genetically determined variant of pseudocholinesterase in two German families with high plasma enzyme activity. Eur. J. Biochem. 99: I979; 65–69

    Google Scholar 

  41. Brock, A., Additional electrophoretic components of cholinesterase in plasma: a phenomenon of no importance to the total plasma cholinesterase activity. J. Clin. Chem.Clin. Biochem. 27: 1989; 429–431

    PubMed  CAS  Google Scholar 

  42. Lockridge, O., C.F. Bartels, T.A. Vaughan, C.K. Wong, S.E. Norton and L.L. Johnson, Complete amino acid sequence of human serum cholinesterase. J. biol. Chem. 262: 1987; 549–557

    PubMed  CAS  Google Scholar 

  43. Yamato, K., I. Huang, H. Muensch, A. Yoshida, H.-W. Goedde and D.P. Agarwal, Amino acid sequence of the active site of human pseudocholinesterase. Biochem. Genet. 21: 1983; 135–145

    Article  PubMed  CAS  Google Scholar 

  44. Arpagaus, M., A. Chatonnet, P. Masson, M. Newton, T.A. Vaughan, C.F. Bartels, C.P. Nogueira, B.N. La Du and O. Lockridge, Use of the polymerase chain reaction for homology probing of butyrylcholinesterases from several vertebrates. J. biol. Chem. 266: 1991; 6966–6974

    PubMed  CAS  Google Scholar 

  45. Neville, L.F., A. Gnatt, R. Padan, B. Seidman and H. Soreq, Anionic site interactions in human butyrylcholinesterase disrupted bytwo single point mutations. J. biol. Chem. 265: 1990; 20735–20738

    PubMed  CAS  Google Scholar 

  46. Chatonnet, A. and O. Lockridge, Comparison of butyrylcholinesterase and actylcholinesterase. Biochem. J. 260: 1989; 625–634

    PubMed  CAS  Google Scholar 

  47. Lockridge, O. and B.N. La Du, Comparison of atypical and usual human serum cholinesterase. J. biol. Chem. 253: 1978; 361–366

    PubMed  CAS  Google Scholar 

  48. Augustinsson, K.B., Cholinesterases: a study in comparative enzymology. Acta Physiol. Scand. 15:1948, Suppl. 52; 1–182

    Google Scholar 

  49. Schmidt, E., F.W. Schmidt, Sex differences of plasma cholinesterases in the rat. Enzyme 23: 1978; 52–55

    PubMed  CAS  Google Scholar 

  50. Wright, P.G., V. de Vos, E. Marcus, M. Ganhao and J. Hattingh, Species variation in plasma cholinesterase activity. Comp. Biochem. Physiol. 70: 1981; 289–291

    CAS  Google Scholar 

  51. Kutty, K.M., Biochemical functions of cholinesterase. Clin. Biochem. 13: 1980; 239–243

    Article  PubMed  CAS  Google Scholar 

  52. Lockridge, O., Substance P hydrolysis by human serum cholinesterase. J. Neurochem. 39: 1982; 106–110

    Article  PubMed  CAS  Google Scholar 

  53. Myers. C., O. Lockridge, B.N. La Du, Hydrolysis of methylprednisolone acetate by human serum cholinesterase. Drug Metab. Dispos. 10: 1982; 279–280

    Google Scholar 

  54. Rao, R.V., A.S. Balasubramanian, The peptidase activity of human serum butyrylcholinesterase:studies using monoclonal antibodies and characterization of the peptidase.J. prot. chem. 12: 1993; 103–110

    Google Scholar 

  55. Ram, Z., M. Molcho, Y.L. Danon, S. Almong, J. Baniel, A. Karni and J. Shemer, The effect of pyridostigmine on respiratory function in healthy and asthmatic volunteers. Israel J. med. Sci. 27: 1991; 664–668

    CAS  Google Scholar 

  56. Gordon, C.J. and L. Fogelson, Relationship between serum cholinesterase activity and the change in body temperature and motor activity in the rat. A dose-response study of diisopropyi iiiuorophosphate. Neurotox. Teratol. 15: 1993; 21–25

    Article  CAS  Google Scholar 

  57. Layer, P.G., Expression and possible functions of cholinesterases during chicken neurogenesis, in: Cholinesterases, J. Massoulié et al. eds. Am. Chem. Soc., Washington, DC, 1991. 350–357

    Google Scholar 

  58. Massoulié, J., S. Bon and M. Vigny, The polymorphism of cholinesterase in vertebrates. Neurochem. int. 2: 1980; 161–184

    Article  Google Scholar 

  59. Ehrlich, G., E. Viegas-Péquinot, D. Ginzberg, L. Sindel, H. Soreq and H. Zakut, Mapping the human acetylcholinesterase gene to chromosome 7q22 by fluorescent in situ hybridization coupled with selective PCR amplification from a somatic hybrid cell panel and chromosome-sorted DNA libraries. Genomics 13: 1992; 1192–1197

    Article  PubMed  CAS  Google Scholar 

  60. Getman, D.K., J.H. Eubanks, S. Camp, G.A. Evans and P. Taylor, The human gene encoding acetylcholinesterases located on the long arm of chromosome 7. Am. J. Hum. Genet. 51: 1992; 170–177

    PubMed  CAS  Google Scholar 

  61. Sorensen, K., U. Brodbeck, A.G. Rasmussen and B. Norgaard-Pedersen, Normal human serum contains two forms of acetylcholinesterase. Clin. Chim. Acta 158: 1986; 1–6

    Article  PubMed  CAS  Google Scholar 

  62. Edwards, J.A. and S. Brimijoin, Divergent regulation of acetylcholinesterase and butyrylcholinesterase in tissues of the rat. J. Neurochem. 38: 1982; 1393–1403

    Article  PubMed  CAS  Google Scholar 

  63. Lapidot-Lifson, Y., C.A. Prody, D. Ginzberg, D. Meytes, H. Zakut and H. Soreq, Coamplification of human acetylcholinesterase and butyrylcholinesterase genes in blood cells: correlation with various leukemias and abnormal megakaryocytopoiesis. Proc. Nat. Acad. Sci. U.S.A. 86: 1989; 4715–4719

    Article  CAS  Google Scholar 

  64. Soreq, H., Y. Lapidot-Lifson and H. Zakut, A role for cholinesterase in tumorigenesis? Cancer Cells 3: 1991; 511–516

    PubMed  CAS  Google Scholar 

  65. Birkhauser, H. and E.A. Zeller, Cholinesterase und Sexualhormone. Helv.chim.Acta 23: 1940; 1460–1464

    Article  CAS  Google Scholar 

  66. Everett, H.W. and C.H. Sawyer, Effects of castration and treatment with sex steroids on synthesis of serum cholinesterase in rat. Endocrinology 39: 1946; 323–343

    Article  PubMed  CAS  Google Scholar 

  67. Illsley, N.P. and C.A. Lamartinière, Endocrine regulation of rat serum cholinesterase activity. Endocrinology 108: 1981; 1737–1743

    Article  PubMed  CAS  Google Scholar 

  68. Lamartinière, C.A.,Growth hormone modulates serum cholinesterase. Endocrinology 118: 1986; 1252 1254

    Google Scholar 

  69. Kambam, J.R., R.J. Naukam, W. Parris, J.J. Franks, S.M. Perry, B.V.R. Sastry and B.E. Smith, Effects of progesterone, estriol, and prostaglandin on pseudocholinesterase activity. Anesthesiology 71:1989; A 883

    Google Scholar 

  70. Sidell, F.R. and A. Kaminskis, Influence of age, sex and oral contraceptives on human blood cholinesterase activity. Clin. Chem. 21: 1975; 1393–1395

    PubMed  CAS  Google Scholar 

  71. Blaauwen, D.H. den, W.A. Poppe and W. Tritschler, Cholinesterase (EC 3.1. 1.8) mit Butyryl-thiocholinjodid als Substrat: Referenzwerte in Abhängigkeit von Alter und Geschlecht unter Berücksichtigung hormoneller Einflüsse und Schwangerschaft. J. Clin. Chem. Clin. Biochem. 21: 1983; 381–386

    Google Scholar 

  72. Lepage, L., Cholinesterase, in: Interpretation of Clinical Laboratory Tests. G. Siest, J. Henny, F. Schiele and D.S. Young, eds. Biochemical Publications, Forster City, Ca, U.S.A., 1985, 209–219

    Google Scholar 

  73. Pritchard, J.A., Plasma cholinesterase activity in normal pregnancy and in eclamptogenic toxemias. Am. J. Obstet. Gynecol. 70: 1955; 1083–1086

    PubMed  CAS  Google Scholar 

  74. Foldes, F.F., T. Arai, H.H. Gentsch and Y. Zarda, The influence of glucocorticoids on plasma cholinesterase. Proc. Soc. exp. Biol. 146: 1974; 918–920

    Article  PubMed  CAS  Google Scholar 

  75. Bradamante, V. and E. Kunec-Vaji“c, Effect ofglucocorticoids on plasma cholinesterase in the rat. Biomed. Biochim. Acta 46: 1987; 439–443

    PubMed  CAS  Google Scholar 

  76. Bradamante, V., E. Kunec-Vaji“c, M. Lisic, I. Dobric and I. Beus, Plasma cholinesterase activity in patients during therapy with dexamethasone or prednisone. Eur. J. clin. Pharmacol. 36: 1989; 253–257

    CAS  Google Scholar 

  77. Tiefenbach, B., L. Jordanov and G. Henninghausen, The glucocorticoid-induced inhibition of cholinesterase activity and the importance for drug interactions. Arch. Pharmacol. 345:1992; Suppl. 1, R101

    Google Scholar 

  78. Seto, Y. and T. Shinohara, Structure-activity relationship of reversible cholinesterase inhibitors including paraquat. Arch. Toxicol. 62: 1988; 37–40

    Article  PubMed  CAS  Google Scholar 

  79. Hansen, W.E. and K. Nehammer, Inhibition of cholinesterase by oxmetidine. Gastroenterology 86: 1984; 1107

    Google Scholar 

  80. Buccafusco, J.J. and M.D. Smith, In vivo and in vitro cholinesterase inhibitor property of the antitumor agent caracemide. Res. Comm. Chem. Pathol. Pharmacol. 67: 1990; 219–227

    CAS  Google Scholar 

  81. Aden-Abdi, Y., T. Villen, O. Ericsson, L.L. Gustaysson and M.L. Dahl-Puustinen, Metrifonate in healthy volunteers: interrelationship between pharmacokinetic properties, cholinesterase inhibition and side-effects.

    Google Scholar 

  82. Bull. WHO 68: 1990; 731–736

    Google Scholar 

  83. Bang, U., J. Viby-Mogensen and J.E. Wiren, The effect of bambuterol on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in subjects heterozygous for abnormal plasma cholinesterase. Acta Anaesthesiol. Scand. 34: 1990; 600–604

    CAS  Google Scholar 

  84. Sharma, M. and L.-A. Svensson, Bambuterol, a selective inhibitor of human plasma butyrylcholinesterase, in: Cholinesterases, J. Massoulié et al. eds., Am. Chem. Soc. Washington, DC, U.S.A., 1991, 345

    Google Scholar 

  85. Berman, H.A. and K. Leonard, Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase. Mol. Pharmacol. 41: 1992; 412–418

    PubMed  CAS  Google Scholar 

  86. Laine-Cessac, P., A. Turcant, A. Premel-Cabic, J. Boyer and P. Allain, Inhibition of cholinesterases by histamine 2 receptor antagonist drugs. Res. Comm. Chem. Path. Pharm. 79: 1993; 185–193

    CAS  Google Scholar 

  87. Kao, Y.J., J. Tellez and D.R. Turner, Dose-dependent effect of metoclopramide on cholinesterases and suxamethonium metabolism. Br. J. Anaesth. 65: 1990; 220–224

    Article  PubMed  CAS  Google Scholar 

  88. Whittaker, M., J.J. Britten, R.J. Wicks, Inhibition of the plasma cholinesterase variants by propranolol. Br. J. Anaesth. 53: 1981; 511–516

    Article  PubMed  CAS  Google Scholar 

  89. Holmes, J.H., P. Kaufer and H. Zwarenstein, Effect of benzodiazepine derivatives on human blood cholinesterase in vitro. Res. Comm. Chem. Path. Pharm. 21: 1978; 367–370

    CAS  Google Scholar 

  90. Hoffman, R.S., G.C. Henry, M.A. Howland, R.S. Weisman, L. Weil and L..R. Goldfrank, Association between life-threatening cocaine toxicity and plasma cholinesterase activity. Ann. Emerg. Med. 21: 1992; 247–253

    CAS  Google Scholar 

  91. Lander, F., E. Pike, K. Hinke, A. Brock and J.B. Nielsen, Anti-cholinesterase agents uptake during cultivation of greenhouse flowers. Arch. Envir. Contam. Toxicol. 22: 1992; 159–162

    Article  CAS  Google Scholar 

  92. Filimore, C.M. and J.E. Lessenger, A cholinesterase testing program for pesticide applicators. J. occup. Med. 35: 1993; 61–70

    Google Scholar 

  93. Wu, Y.Q., J.D. Wang, J.S. Cheng, S.C. Chung and S.Y. Hwang, Occupational risk of decreased plasma cholinesterase among pesticide production workers in Taiwan. Am. J. Industr. Med. 16: 1989; 659–666

    CAS  Google Scholar 

  94. Kamal, A.A., N.T. Elgarthy, F. Maklady, M.A. Mostafa and A. Massoud, Serum cholinesterase and liver function among a group of organophosphorus pesticides sprayers in Egypt. J. toxicol. clin. exper. 10: 1990; 427–435

    CAS  Google Scholar 

  95. Faustini, A., F. Arpala, P. Pagliarella, F. Forastiere, P. Papini and C.A. Perucci, Monitoraggio delle colinesterasi in lavoratori agricoli e commercianti esposito ad esteri fosforici e carbammati. Med. Lavoro 83: 1992; 135–145

    PubMed  CAS  Google Scholar 

  96. Rama, D.B. and K. Jaga, Pesticide exposure and cholinesterase levels among farm workers in the Republic of South Africa. Sci. Total Envir. 122: 1992; 315–319

    Article  CAS  Google Scholar 

  97. Lander, F., A. Brock, E. Pike, K. Hinke, Chronic subclinical intake of dietary anticholinesterase agents during the spraying season. Food Chem. Toxicol. 30: 1992; 37–40

    Article  CAS  Google Scholar 

  98. Brock, A. and V. Brock, Plasma cholinesterase activity in a healthy population group with no occupational exposure to known cholinesterase inhibitors: relative influence of some factors related to normal inter-and intra-individual variations. Scand. J. Clin. Lab. Invest. 50: 1990; 401–408

    Article  PubMed  CAS  Google Scholar 

  99. Prody, C.A., P. Dreyfus, R. Zamir, H. Zakut and H. Soreq, De novo amplification within a “silent” human cholinesterase gene in a family subjected to prolonged exposure to organophosphorous insecticides. Proc. Nat. Acad. Sci. US.A. 86: 1989; 690–694

    Article  CAS  Google Scholar 

  100. Soreq, H. and H. Zakut, Amplification of butyrylcholinesterase and acetylcholinesterase genes in normal and tumor tissues: putative relationship to organophosphorous poisoning. Pharma. Res. 7: 1990; 1–7

    Article  CAS  Google Scholar 

  101. Panteghini, M. and R. Bonora, Evaluation of a new continuous colorimetric method for determination of serum pseudocholinesterase catalytic activity and its application to a centrifugal fast analyser. J. Clin. Chem. Clin. Biochem. 22: 1984; 671–676

    PubMed  CAS  Google Scholar 

  102. Rostron, P. and T. Higgins, Serum pseudocholinesterase and dibucaine numbers as measured with the Technicon RA-1000 analyzer. Clin. Chem. 34: 1988; 1924–1925

    PubMed  CAS  Google Scholar 

  103. Hasselberg, S., L. Mauck and D Nealon, Development of a Kodak Ektachem thin-film assay for serum cholinesterase. Clin. Chem. 35: 1989; 1120

    Google Scholar 

  104. Takeuchi, T., Y. Kabasawa, R. Horikawa and T. Tanimura. Mechanized assay of serum cholinesterase by specific colorimetric detection of released acid. Clin. Chim. Acta 205: 1992; 117–126

    Article  CAS  Google Scholar 

  105. Krull, N.B., J. Kropf and A.M. Gressner, Influence of reagent composition of atypical pseudocholinesterase activity measurement: comparison of a manual and an automated method and implications for routine. Eur. J. Clin. Chem. Clin. Biochem. 30: 1992; 545–546

    PubMed  CAS  Google Scholar 

  106. Thomsen, T., H. Kewitz and O. Pleul. Estimation of cholinesterase activity (EC 3.1.1.7; 3.1.1.8) in undiluted plasma and erythrocytes as a tool for measuring in vivo effects of reversible inhibitors. J. Clin. Chem. Clin. Biochem. 26: 1988; 469–475

    PubMed  CAS  Google Scholar 

  107. Vorschlag zum Arzneibuch der DDR, 2. Ausg., Bestimmung der Aktivität der Cholinesterase in Serum. Zbl. Pharm. 119: 1980; 1293–1297

    Google Scholar 

  108. Alcini, D., M. Maroni, A. Colombi, D. Xaiz and V. Foa, Evaluation of a standardized European method for the determination of cholinesterase activity in plasma and erythrocytes. Med. Lavoro 79: 1988; 42–53

    CAS  Google Scholar 

  109. Deutsche Gesellschaft far Klinische Chemie, Proposal for standard methods for the determination of enzyme catalytic concentrations in serum and plasma at 37°C, II. Cholinesterase (acylcholine acylhydrolase, EC 3.1.1.8) Eur. J. Clin. Chem. Clin. Biochem. 30: 1992; 163–170

    Google Scholar 

  110. Rama, D.B.K. and M. Deneys, Quality control of red blood cell cholinesterase estimations. South Mr. Med. J. 81: 1992; 530

    CAS  Google Scholar 

  111. Whittaker, M., J.W. Jones and J. Braven, Immunological studies of plasma cholinesterase during pregnancy and the puerperium. Clin. Chim. Acta 199: 1991; 223–230

    Article  PubMed  CAS  Google Scholar 

  112. Lepage, L. F. Schiele, R. Gueguen and G. Siest, Total cholinesterase in plasma: Biological variations and reference limits. Clin. Chem. 31: 1985; 546–550

    PubMed  CAS  Google Scholar 

  113. Brock, A., Immunoreactive plasma cholinesterase (EC 3.1.1.8) substance concentration compared with cholinesterase activity concentration and albumin: Inter-and intra-individual variations in a healthy population group. J. Clin. Chem. Clin. Biochem. 28: 1990; 851–856

    PubMed  CAS  Google Scholar 

  114. Pourrat, O., R. Robert, J.P. Neau, P. Deleplanque and D. Alcalay, Crises cholinergiques chez un myasthenique traité par échanges plasmatiques et anticholinesterasiques. Aim. Med. Int. 139: 1988; 51–52

    Google Scholar 

  115. Evans, R.T. and A. Robinson, The combined effects of pregnancy and repeated plasma exchange on serum cholinesterase activity. Acta anaesthesiol. Scand. 28: 1984; 44–46

    CAS  Google Scholar 

  116. Schuh, F.T., Pseudocholinesterase activity of human whole blood, bank blood and blood protein solutions. Anaesthesist 24: 1975; 103–106

    PubMed  CAS  Google Scholar 

  117. Huizenga, J.R., K. van der Belt and C.H. Gips, The effect of storage at different temperatures on cholinesterase activity in human serum. J. Clin. Chem. Clin. Biochem. 23: 1985; 283–285

    PubMed  CAS  Google Scholar 

  118. Balland, M., M. Vincent-Viry and J. Henny, Effect of long-term storage on human plasma cholinesterase activity. Clin. Chim. Acta 211: 1992; 129–131

    Article  PubMed  CAS  Google Scholar 

  119. Braun, B.-E., R. Goes, M. Tryba, D. Huppe, H.-D. Kuntz and M. Krieg, Anstieg der CholinesteraseAktivitat bei Patienten mit dekompensierter Leberzirrhose nach Gabe von gerinnungsaktivem Frischplasma (FFP). Lab. med. 15: 1991; 485–489

    Google Scholar 

  120. Lovely, M.J., S.K. Patteson, F.J. Beuerlein and J.T. Chesney, Perioperative blood transfusion may conceal atypical pseudocholinesterase. Anest. Analg. 70: 1990; 326–327

    Article  CAS  Google Scholar 

  121. Puche, E., E. Gomez-Valverde, M- Garcia-Morillas, F. Jorde F. Fajardo and J.M. Garcia Gil, Postoperative decline in plasma aspirin-esterase and cholinesterase activity in surgical patients. Acta anaesthesiol. Scand. 37: 1993; 20–22

    CAS  Google Scholar 

  122. Burnett, W. and Y. Conen: Liver function after surgery: A study of 50 cases with particular reference to serum cholinesterase. Br. J. Anaesth. 27: 1955; 66–71

    Article  PubMed  CAS  Google Scholar 

  123. Ryan, D.W., Postoperative serum cholinesterase activity following successful renal transplantation. Br. J. Anaesth. 51: 1979; 881–884

    Article  PubMed  CAS  Google Scholar 

  124. Waterlow, J., Liver cholinesterase in malnourished infants. Lancet 1: 1950; 908–909

    Article  PubMed  CAS  Google Scholar 

  125. Barclay, G.P.T., Pseudocholinesterase activity as a guide to prognosis in malnutrition. Am. J. Clin. Path. 59: 1973; 712–716

    PubMed  CAS  Google Scholar 

  126. Venkataraman, B.V., J. Thangam, P.S. Shetty and P.M. Stephen, Cholinesterase in starvation. Ind. J. Physiol. Pharmacol. 26: 1982; 137–140

    CAS  Google Scholar 

  127. Foldes, F.F., Enzymes in Anesthesiology. Springer, New York, 1978, 107–131

    Book  Google Scholar 

  128. Jenike, M.A., M. Albert, L. Baer and J. Gunther, Oral physostigmine treatment for primary dementia: a double-blind placebo-controlled inpatient trial. J. Geriat. Psychiat. Neurol. 3: 1990; 13–16

    Article  CAS  Google Scholar 

  129. Volger, B.W., Alternatives in the treatment of memory loss in patients with Alzheimer’s disease. Clin. Pharm. 10: 1991; 447–456

    PubMed  CAS  Google Scholar 

  130. Davis, K.L., L.J. Thai, E.R. Gamzu, C.S. Davis, R.F. Woolson, S.I. Gracon, D.A. Drachman, L.S. Schneider, P.J. Whitehouse, T.m. Hoover and the Tacrine Collaborative Study Group, A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer’s disease. New Engl. J. Med. 327: 1992; 1253–1259

    Google Scholar 

  131. Mesulam, M.M. and C Goula, Shifting patterns of cortical cholinesterase in Alzheimer’s disease: implications for treatment, diagnosis, and pathogenesis. Adv. Neurol. 51: 1990; 235–240

    PubMed  CAS  Google Scholar 

  132. Arendt, T., M.K. Brueckner, M. Lange and V. Bigl, Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer’s disease resemble embryonic development: a study of molecular forms. Neurochem. Int. 21: 1992; 381–396

    Article  PubMed  CAS  Google Scholar 

  133. Wright, C.I., C. Guela and M.M. Mesulam, Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer disease. Proc. Nat. Acad. Sci. U.S.A. 90: 1993; 683–686

    Article  CAS  Google Scholar 

  134. Atack, J.R., C. May, J.A. Kaye, A.D. Kay and S.I. Rapoport, Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type. Ann. Neurol. 23: 1988; 161–167

    Article  PubMed  CAS  Google Scholar 

  135. Sirvioe, J. and P.J. Riekkinen, Brain and cerebrospinal fluid cholinesterases in Alzheimer’s disease, Parkinson’s disease and aging A critical review of clinical and experimental studies. J. Neur.Transmiss. 4: 1992; 337–358

    Article  Google Scholar 

  136. Bonham, J.R., G. Dale, D.J. Scott and J. Waggett, Diagnostic value of acetylcholinesterase/butyrylcholinesterase ratio in Hirschsprung’s disease. Am. J. Clin. Path. 90: 1988; 520–521

    PubMed  CAS  Google Scholar 

  137. Rasmussen Loft, A.G., Determination of amniotic fluid acetylcholinesterase activity in the antenatal diagnosis of foetal malformations: The first ten years. J. Clin. Chem. Clin. Biochem. 28: 1990; 893–911

    Google Scholar 

  138. Kutty, K.M., R. Jain, S.N. Huang and K. Kean, Serum pseudocholinesterase:high density lipoprotein cholesterol ratio as an index of risk for cardiovascular disease. Clin. Chim. Acta 115: 1981; 55–61

    Article  PubMed  CAS  Google Scholar 

  139. enschläger, G., M. Schrappe-Bächer, M. Steffen, B. Bürger and B. Allolio, Erhebung des Ernährungszustandes–ein Bestandteil der klinischen Routine-Diagnostik: Cholinesterase-Aktivität als Ernährungsindikator. Klirr. Wschr. 67: 1989; 1101–1107

    Article  Google Scholar 

  140. Novacek, G., H. Vogelsang, B. Schmidt and H. Lochs, Are single measurements of pseudocholinesterase and albumin markers for inflammatory activity or nutritional status in Crohn’s disease? Wien. Klirr. Wschr. 105: 1993; 111–115

    CAS  Google Scholar 

  141. Wellmann, W., R. Kubale, T.G.A. Nyman, J. Oestmann, E. Schmidt and F.W. Schmidt, Enzyme screening in inflammatory bowel disease: A preliminary report, in: Progress in Clinical Enzymology. D.M. Goldberg, M. Werner, eds. Masson, New York, 1980, 145–149

    Google Scholar 

  142. Tromm, A., D. Huppe, I. Thau, U. Schwegler, H.D. Kuntz, M. Krieg and B. May, Die Serumcholinesterase als Aktivitätsparameter bei chronisch entzündlichen Darmerkrankungen. Z. Gastroenterol. 30: 1992; 449–453

    PubMed  CAS  Google Scholar 

  143. Schmidt, E. and F.W. Schmidt, Mitreaktionen der Leber bei systemischen Erkrankungen unter besonderer Berücksichtigung der Infektionen, in: Die Leber bei extrahepatischen Erkrankungen und Stoffwechselleiden. W. Tittor, G. Schwalbach, eds. Demeter, Gräfelfing 1984, 41–76

    Google Scholar 

  144. Guder, W.G., Anwendung von Bewertungsverfahren: Modell Lebererkrankungen, in: Validität klinisch-chemischer Befunde, H. Lang, W. Rick, H. Büttner, eds., Springer, Berlin, 1980, 84–91

    Chapter  Google Scholar 

  145. Schmidt, E. and F.W. Schmidt, Strategie-Probleme bei der Diagnostik von Lebererkrankungen, in: Strategien für den Einsatz klinisch-chemischer Untersuchungen, H. Lang, W. Rick, H. Büttner, eds. Springer, Berlin, 1982, 152–169

    Google Scholar 

  146. Lautz, H.U., E. Schmidt, F.W. Schmidt and M. Barthels, Korrelationen zwischen Einschränkung der Sekretionsleistung der Leber und dem Austritt von Zellenzymen. Z. Gastroenterol. 171979;99–105

    Google Scholar 

  147. Schmidt, E. and F.W. Schmidt, Enzyme diagnosis in diseases of the liver and the biliary system. Adv. Clin. Enzymol. 1: 1979; 239–292

    Google Scholar 

  148. Tinè, F. and L. Pagliaro, Cirrhosis and its recognition in asymptomatic subjects with aminotransferase elevation. Hepatology 11: 1990; 516–517

    Article  PubMed  Google Scholar 

  149. Nomura, F., K. Olmishi, H. Koen, Y. Hiyama, T. Nakayama, Y. Itoh, K. Shirai, Y. Saitoh and K. Okuda, Serum cholinesterase in patients with fatty liver. J. Clin. Gastroenterol. 8: 1986; 599–602

    Article  PubMed  CAS  Google Scholar 

  150. Hada, T., T. Ohue, H. Imanishi, H. Nakaoka, M. Fujikura, T. Yamamoto, Y. Amuro and K. Higashino, Alteration of serum cholinesterase isozyme in patients with liver cirrhosis. Clin. Chim. Acta 178: 1988; 111–112

    Article  PubMed  CAS  Google Scholar 

  151. Schmidt, E. and F.W. Schmidt, Enzyme patterns in liver failure, in: Artificial Liver Support. G. Brunner, F.W. Schmidt, eds. Springer, Berlin, 1987, 8–17

    Google Scholar 

  152. Burghardt, M., A. Henze, U. Russmann, J. Lobers, E. Schmidt, F.W. Schmidt, On the prognosis of liver cirrhosis, in: Experimental and Clinical Hepatology. C.E. Broelsch, O. Zelder, eds. MTP Press, Lancaster, 1986, 80–88

    Chapter  Google Scholar 

  153. Schmidt, E., F.W. Schmidt S. Ohlendorf, R. Raupach, T. Wittig, C.E. Broelsch and R. Pichlmayr, Enzyme patterns in serum after liver transplantation, in: A. Burlina, L. Galzigna, eds. Clinical Enzymology Symposia 5. Piccin, Padua, 1986, 143–156

    Google Scholar 

  154. Irrgang, B., N. Adam, A. Schwab and F. Przybylski, Computer-supported decision making in liver diagnosis based on a graphical presentation of laboratory data. J. Clin. Chem. Clin. Biochem. 28: 1990; 733

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ellen, Schmidt, F.W. (1994). Serum Cholinesterase: Genetics, Enzymology, Diagnostic Use and the Association with Clinical Disorders. In: Mackness, M.I., Clerc, M. (eds) Esterases, Lipases, and Phospholipases. NATO ASI Series, vol 266. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0993-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-0993-0_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-0995-4

  • Online ISBN: 978-1-4899-0993-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics